Difficulties in Kawasaki Disease Diagnosis and Treatment in Children

Difficulties in Kawasaki Disease Diagnosis and Treatment in Children

The Kawasaki disease is the acute vasculitis specific to the childhood that affects the medium-sized arteries and causes the coronary aneurysms in about 25% of the patients untreated. This disease is one of the causes of the heart diseases acquired in the children in the economically developed count...

Full description

Bibliographic Details
Main Authors:	A. E. Dobrovanov, D. Dmytriev, K. Yu. Dmytrieva, L. Hustavova
Format:	Article
Language:	Russian
Published:	Ltd. “The National Academy of Pediatric Science and Innovation” 2021-01-01
Series:	Rossijskij Vestnik Perinatologii i Pediatrii
Subjects:	children kawasaki disease cholestasis coronary artery aneurysms intravenous immunoglobulins acetylsalicylic acid
Online Access:	https://www.ped-perinatology.ru/jour/article/view/1300

Similar Items

Initial Intravenous γ-Globulin Treatment Failure in Iranian Children with Kawasaki Disease
by: Sara Kashef, et al.
Published: (2005-09-01)

Effect of Early Intravenous Immunoglobulin Therapy in Kawasaki Disease: A Systematic Review and Meta-Analysis
by: Fan Yan, et al.
Published: (2020-11-01)

Heart Rate, Responsiveness to Intravenous Immunoglobulin, and Coronary Artery Aneurysms in Kawasaki Disease
by: Miyakoshi, Chisato
Published: (2019)

Kawasaki disease: two case reports from the Aga Khan Hospital, Dar es Salaam-Tanzania
by: Mariam Noorani, et al.
Published: (2018-10-01)

Clinical relevance of the risk factors for coronary artery lesions in Kawasaki disease
by: Ken-Pen Weng, et al.
Published: (2012-01-01)

Revised recommendations of the Italian Society of Pediatrics about the general management of Kawasaki disease
by: Alessandra Marchesi, et al.
Published: (2021-01-01)

Perspective of Immunopathogenesis and Immunotherapies for Kawasaki Disease
by: Lung Chang, et al.
Published: (2021-07-01)

Critical Overview of the Risk Scoring Systems to Predict Non-Responsiveness to Intravenous Immunoglobulin in Kawasaki Syndrome
by: Donato Rigante, et al.
Published: (2016-02-01)

Kawasaki Disease in Children Older Than 10 Years: A Clinical Experience From Northwest India
by: Ankur Kumar Jindal, et al.
Published: (2020-02-01)

Kawasaki disease: giant aneurysm with a large thrombus of the left coronary artery
by: Alakananda Ghosh, et al.
Published: (2011-04-01)

Kawasaki disease for dermatologists
by: Aman Gupta, et al.
Published: (2016-01-01)

Kawasaki disease: guidelines of the Italian Society of Pediatrics, part I - definition, epidemiology, etiopathogenesis, clinical expression and management of the acute phase
by: Alessandra Marchesi, et al.
Published: (2018-08-01)

Cyclosporine for refractory Kawasaki disease with psoriasiform eruption
by: Mara Leyendecker, BS, et al.
Published: (2021-04-01)

Prediction of nonresponsiveness to medium-dose intravenous immunoglobulin (1 g/kg) treatment: an effective and safe schedule of acute treatment for Kawasaki disease
by: Kyung Pil Moon, et al.
Published: (2016-04-01)

The Impact of Moderate-Dose Acetylsalicylic Acid in the Reduction of Inflammatory Cytokine and Prevention of Complication in Acute Phase of Kawasaki Disease: The Benefit of Moderate-Dose Acetylsalicylic Acid
by: Jung Eun Kwon, et al.
Published: (2020-10-01)

Association between maternal age and outcomes in Kawasaki disease patients
by: Wei-Dong Huang, et al.
Published: (2019-07-01)

The expression and significance of serum caveolin-1 in patients with Kawasaki disease
by: Feng Zhu, et al.
Published: (2020-01-01)

A 10-year cross-sectional retrospective study on Kawasaki disease in Iranian children: incidence, clinical manifestations, complications, and treatment patterns
by: Payman Sadeghi, et al.
Published: (2021-04-01)

Neutropenia Is Not Associated With the Outcomes in Patients With Kawasaki Disease
by: Yunjia Tang, et al.
Published: (2021-06-01)

Predictors of Intravenous Immunoglobulin (IVIG) Resistance in Children with Kawasaki Disease in Calabria Region, Italy
by: Valentina Talarico, et al.
Published: (2019-02-01)

Effect of different doses of aspirin on the prognosis of Kawasaki disease
by: Jinxin Wang, et al.
Published: (2020-06-01)

Resistant Kawasaki disease, case report and literatures review
by: M.J. Saffar, et al.
Published: (2006-01-01)

Evaluation of high-dose aspirin elimination in the treatment of Kawasaki disease in the incidence of coronary artery aneurysm
by: Farima Sanati, et al.
Published: (2021-01-01)

Neurological involvement in Kawasaki disease: a retrospective study
by: Xiaoliang Liu, et al.
Published: (2020-07-01)

Intravenous Immunoglobulin Treatment in Kawasaki Disease Decreases the Incidence of Myopia
by: Hun-Ju Yu, et al.
Published: (2021-03-01)

Review of Kawasaki Disease
by: Rani Shah, et al.
Published: (2018-01-01)

Effectiveness of intravenous immunoglobulin alone and intravenous immunoglobulin combined with high-dose aspirin in the acute stage of Kawasaki disease: study protocol for a randomized controlled trial
by: Ho-Chang Kuo, et al.
Published: (2018-06-01)

Review of Kawasaki Patients in Yazd
by: P Roozbeh, et al.
Published: (2009-01-01)

KAWASAKI DISEASE IN KAZAKHSTAN: AN UNMET CLINICAL AND PUBLIC HEALTH ISSUE?
by: Dimitri Poddighe, et al.
Published: (2020-08-01)

Heart and coronary artery damage related to Kawasaki syndrome
by: A. A. Leontyeva, et al.
Published: (2016-03-01)

Kawasaki syndrome: Risk factors for coronary artery aneurysms
by: A. V. Torbyak, et al.
Published: (2016-03-01)

Editorial: Kawasaki Disease
by: Mamoru Ayusawa, et al.
Published: (2021-01-01)

Laporan Kasus: Penyakit Kawasaki Atipikal
by: Budi Setiabudiawan, et al.
Published: (2011-09-01)

CLINICAL MANIFESTATION, DIAGNOSTICS AND TREATMENT OF KAWASAKI DISEASE: KNOWN DATA AND UNSOLVED QUESTIONS
by: G. А. Lyskina, et al.
Published: (2013-02-01)

Unusual imaging presentation of infantile atypical Kawasaki disease
by: Nishith Kumar, et al.
Published: (2016-07-01)

Comparison between Kawasaki disease with lymph-node-first presentation and Kawasaki disease without cervical lymphadenopathy
by: Jung Ok Kim, et al.
Published: (2016-02-01)

Kawasaki disease: guidelines of Italian Society of Pediatrics, part II - treatment of resistant forms and cardiovascular complications, follow-up, lifestyle and prevention of cardiovascular risks
by: Alessandra Marchesi, et al.
Published: (2018-08-01)

Prediction of repeated intravenous immunoglobulin resistance in children with Kawasaki disease
by: Yaheng Lu, et al.
Published: (2021-09-01)

EXPERIENCE OF INTRAVENOUS INJECTION OF NORMAL HUMAN IMMUNOGLOBULIN IN A PATIENT WITH KAWASAKI SYNDROME
by: T. V. Sleptsova, et al.
Published: (2014-07-01)

A comparison of efficacy of six prediction models for intravenous immunoglobulin resistance in Kawasaki disease
by: Weiguo Qian, et al.
Published: (2018-03-01)